Appaloosa Management’s Allergan plc AGN Stock Holding History

Appaloosa Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$46.9M	Buy	+150,000	New	+$44.7M	0.93%	29

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Appaloosa Management's AGN Position: Q4 2015 in Review

Appaloosa Management opened a new position in Allergan plc (AGN) in Q4 2015: 150,000 shares worth $46.9M. The stake represents 0.93% of the portfolio and ranks #29 among its holdings.

1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Appaloosa Management held 150,000 shares of Allergan plc worth $46.9M as of Q4 2015.
Allergan plc was a new Appaloosa Management position in Q4 2015.
Allergan plc made up 0.93% of Appaloosa Management's portfolio in Q4 2015, its #29 holding.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Appaloosa Management's 13F filing for Q4 2015, filed 12 Feb 2016.